Search

Your search keyword '"Fafi‐kremer, S"' showing total 302 results

Search Constraints

Start Over You searched for: Author "Fafi‐kremer, S" Remove constraint Author: "Fafi‐kremer, S"
302 results on '"Fafi‐kremer, S"'

Search Results

101. Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study.

102. Humoral immune response after COVID-19 infection or BNT162b2 vaccine among older adults: evolution over time and protective thresholds.

104. Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients.

105. Combining predictive markers for severe COVID-19: Torquetenovirus DNA load and SARS-CoV-2 RNAemia.

106. Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine.

107. COVID-19 exposure in SARS-CoV-2-seropositive hospital staff members during the first pandemic wave at Strasbourg University Hospital, France.

108. Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort.

109. Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab.

110. Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection.

111. Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19.

112. Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019.

113. Presence of active myocarditis at the 6 month follow-up appointment for a severe form of COVID-19: a case report.

114. SARS-Cov-2 Seroprevalence in a French Kidney Transplant Center Located Within a "High-risk" Zone.

115. Therapeutic prevention of COVID-19 in elderly: a case-control study.

116. Outbreak of SARS-CoV-2 infection in a long-term care facility after COVID-19 BNT162b2 mRNA vaccination.

117. Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2.

118. Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection.

119. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.

120. Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.

121. Rapid Antigen Test Combined with Chest Computed Tomography to Rule Out COVID-19 in Patients Admitted to the Emergency Department.

122. Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19.

123. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.

125. Favorable outcomes among neonates not separated from their symptomatic SARS-CoV-2-infected mothers.

126. Microparticles in COVID-19 as a link between lung injury extension and thrombosis.

127. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine.

128. Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.

130. Clinical and Virological Follow-Up of a Cohort of 76 COVID-19 Older Hospitalized Adults.

131. Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.

132. Quantitative description of SARS-CoV-2 RT-PCR, a cohort of 76 COVID-19 older hospitalized adults.

133. Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML.

135. SARS-CoV-2 viral load in nasopharyngeal swabs in the emergency department does not predict COVID-19 severity and mortality.

136. Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients.

137. Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study.

138. Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France.

139. Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients-Results from a proof-of-concept study.

140. Biomarkers of Cytokine Release Syndrome Predict Disease Severity and Mortality From COVID-19 in Kidney Transplant Recipients.

141. D-Dimers Level as a Possible Marker of Extravascular Fibrinolysis in COVID-19 Patients.

142. Inadequate Immune Humoral Response against JC Virus in Progressive Multifocal Leukoencephalopathy Non-Survivors.

143. Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth.

144. Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies.

145. Evaluation of Humoral Immunity to SARS-CoV-2: Diagnostic Value of a New Multiplex Addressable Laser Bead Immunoassay.

146. In-depth virological assessment of kidney transplant recipients with COVID-19.

147. Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study.

148. SARS-CoV-2 Pneumonia in Hospitalized Asthmatic Patients Did Not Induce Severe Exacerbation.

149. Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France.

150. Coronavirus disease 2019 3 months after hematopoietic stem cell transplant: A pediatric case report.

Catalog

Books, media, physical & digital resources